D-0154-2025 Class II Ongoing

Recalled by Macleods Pharmaceuticals Ltd — Mumbai

FDA drug recall D-0154-2025 was initiated by Macleods Pharmaceuticals Ltd on Nov 25, 2024 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is ongoing. Affected quantity: 15,744 30-count bottles.

Recall details

Product Type
Drugs
Report Date
Dec 25, 2024
Initiation Date
Nov 25, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
15,744 30-count bottles

Product description

Olanzapine Tablets, USP 2.5 mg, 30-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured for: Macleods Pharma USA Inc. Princeton, NJ,08540: Manufactured by: Macleods Pharmaceuticals, Ltd. Baddi Himachal Pradesh, INDIA, NDC 33342-067-07.

Reason for recall

Failed Impurities/Degradation Specifications

Distribution pattern

Nationwide in the USA

Code information

Lot# BOB12318A Exp 07/31/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0154-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0154-2025. Report a data issue: hello@regdatalab.com.